Market Cap

Ascletis Pharma, Inc. Market Capitalization:

HK$14.50 Billion

HKD as of Jan. 1, 2026

US$1.86 Billion

business Ascletis Pharma, Inc. Company Profile

Ascletis Pharma, Inc. Main Stock Listing

HKEX: 1672

Market Capitalization History of Ascletis Pharma, Inc.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $158.96 B
Vertex Pharmaceuticals Incorporated $115.92 B
CSL Limited $95.75 B
Regeneron Pharmaceuticals, Inc. $82.28 B
Marinomed Biotech AG $70.11 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $968.50 B
Johnson & Johnson $499.57 B
AbbVie $405.28 B
Roche $332.12 B
UnitedHealth Group $304.72 B

Yearly evolution of Ascletis Pharma, Inc. market cap

Date Market Cap YoY Change
Jan. 1, 2026 HK$14.50 B 251.72%
Jan. 1, 2025 HK$4.12 B 209.44%
Jan. 1, 2024 HK$1.33 B -73.52%
Jan. 1, 2023 HK$5.03 B 18.39%
Jan. 1, 2022 HK$4.25 B 41.79%
Jan. 1, 2021 HK$3.00 B -32.53%
Jan. 1, 2020 HK$4.44 B -35.86%
Jan. 1, 2019 HK$6.93 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Ascletis Pharma, Inc. Categories

China languages Healthcare languages Biotechnology
China Healthcare China Biotechnology

Stocks & Indices

Ascletis Pharma, Inc. has the following listings and related stock indices.


Stock: HKEX: 1672

Stock: FSX: 2VJ

Stock: OTC: ASCLF

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.